Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life

Optimal therapy of patients with steroid-resistant primary focal segmental glomerulosclerosis (FSGS) remains controversial. This report describes the initial study design, baseline characteristics, and quality of life of patients enrolled in the FSGS Clinical Trial, a large multicenter randomized st...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gipson, Debbie S., Trachtman, Howard, Kaskel, Frederick J., Radeva, Milena K., Gassman, Jennifer, Greene, Tom H., Moxey-Mims, Marva M., Hogg, Ronald J., Watkins, Sandra L., Fine, Richard N., Middleton, John P., Vehaskari, V. M., Hogan, Susan L., Vento, Suzzane, Flynn, Patti A., Powell, Leslie M., McMahan, June L., Siegel, Norman, Friedman, Aaron L.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3306823/
https://ncbi.nlm.nih.gov/pubmed/21178977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ki.2010.485
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares